New Analysis of Organon’s VTAMA® (tapinarof) cream, 1% Phase 3 Data Shows Atopic Dermatitis Disease Activity Remained Low After Treatment-Free Interval in Adults and Children 2 Years of Age and Older Business Wire Source link
(delgocitinib) Cream in Chinese Patients with Moderate to Severe Chronic Hand Eczema (CHE) Business Wire Source link
Read Time:3 Minute, 44 Second New Jersey (United States) – The Atopic Eczema Treatment Market research report provides all the information related to the industry. It gives the market’s outlook by giving authentic data to its client, which helps to make essential decisions. It provides an overview of the market, which includes its […]
The Food and Drug Administration has approved a first-of-its-kind treatment for vitiligo, a condition that causes patches of discoloration on the skin and, currently, has few other therapeutic options. The treatment, known as ruxolitinib, is now the only one approved in the U.S. to repigment skin in people with the most common, “nonsegmental” form of […]